drug injury lawsuit

Valsartan Litigation Update: Hetero Settles Personal Injury and Economic Loss Claims

One of the key players involved in the ongoing valsartan NDMA litigation has agreed to a settlement of valsartan lawsuits, providing some relief to individuals impacted by the contaminated blood pressure medication. The U.S. District Judge presiding over the valsartan lawsuits has been informed that a preliminary settlement agreement has been reached with Hetero Drugs, […]

Valsartan Litigation Update: Hetero Settles Personal Injury and Economic Loss Claims Read More »

Wegovy Gastroparesis Lawsuits: Patients Seek Compensation for Stomach Paralysis Injuries

Despite the growing popularity of Novo Nordisk’s semaglutide-based Wegovy as a solution for weight loss, an alarming number of Wegovy users have reported severe gastrointestinal complications, including a debilitating condition known as gastroparesis. As patients struggle with the life-altering effects of gastroparesis, or stomach paralysis, many are considering legal claims, seeking compensation and accountability from

Wegovy Gastroparesis Lawsuits: Patients Seek Compensation for Stomach Paralysis Injuries Read More »

Ozempic Lawsuit: Iowa Man Seeks Justice for Devastating Health Problems

An Iowa man has taken legal action against the manufacturers of Ozempic, a widely prescribed diabetes drug. In a product liability lawsuit filed last week in the U.S. District Court for the Northern District of Iowa, plaintiff Shawn Derrick alleges that Novo Nordisk and its subsidiaries failed to provide adequate warnings about the health risks

Ozempic Lawsuit: Iowa Man Seeks Justice for Devastating Health Problems Read More »

Lawsuits Over Ozempic, Other GLP-1 Drugs: Are Label Warnings Adequate?

In recent years, millions of Americans have turned to medications like Ozempic, Wegovy, and Mounjaro, which belong to the class of drugs known as glucagon-like peptide-1 receptor agonists (GLP-1 RA), for weight loss and diabetes management. These drugs have been aggressively promoted by their manufacturers as safe and effective. However, a growing number of former

Lawsuits Over Ozempic, Other GLP-1 Drugs: Are Label Warnings Adequate? Read More »

First Valsartan NDMA Cancer Lawsuit Cleared to Proceed to Trial

More than five years after the initial valsartan recalls, the U.S. District Judge overseeing the valsartan litigation has greenlit the first trial against manufacturers and distributors of the tainted generic blood pressure drug. Over 1,200 valsartan lawsuits have been filed, with individuals alleging that changes to the manufacturing process resulted in the distribution of valsartan

First Valsartan NDMA Cancer Lawsuit Cleared to Proceed to Trial Read More »

Zantac Cancer Lawsuit: Settlement Reached in 4,000 Claims Involving Recalled Heartburn Drug

Sanofi, the pharmaceutical company behind Zantac (ranitidine), has recently announced a significant settlement agreement to resolve approximately 4,000 cancer lawsuits filed in state courts across the United States. Although this settlement marks a step towards resolution, Sanofi still faces tens of thousands of pending claims related to the recalled heartburn drug, the majority of them

Zantac Cancer Lawsuit: Settlement Reached in 4,000 Claims Involving Recalled Heartburn Drug Read More »

Ozempic Use Led to Gastrointestinal Side Effects, Gallbladder Removal: Lawsuit

A lawsuit filed late last month in the U.S. District Court for the Eastern District of Pennsylvania sheds light on the potential severity of the gastrointestinal side effects allegedly linked to the popular diabetes and weight-loss drug Ozempic. The lawsuit was filed by Miquana Renteria, a Texas woman who alleges that Ozempic manufacturer Novo Nordisk

Ozempic Use Led to Gastrointestinal Side Effects, Gallbladder Removal: Lawsuit Read More »

Lawsuit Against Ozempic, Trulicity Manufacturers Alleges Gastroparesis Side Effects

A Pennsylvania woman has taken legal action against the manufacturers of Ozempic and Trulicity, alleging that she suffered severe and painful injuries, including bowel obstruction and severe nausea, as a result of gastroparesis side effects linked to these diabetes drugs. Danielle Kindrew filed a product liability lawsuit against Novo Nordisk and Eli Lilly, the makers

Lawsuit Against Ozempic, Trulicity Manufacturers Alleges Gastroparesis Side Effects Read More »

Wegovy and Ozempic Lawsuits: The Risk of Stomach Paralysis Side Effects

Drug manufacturer Novo Nordisk faces a growing number of lawsuits accusing the company of failing to warn users about the potential risk of stomach paralysis or gastroparesis associated with Ozempic and its sister drug Wegovy. The use of medications like Wegovy and even Ozempic for weight loss has become increasingly popular due to evidence that

Wegovy and Ozempic Lawsuits: The Risk of Stomach Paralysis Side Effects Read More »

FDA Investigates Ozempic, Other Diabetes and Weight-Loss Drugs for Suicide, Hair Loss Side Effects

The U.S. Food and Drug Administration (FDA) has launched an investigation into the potential risks associated with the use of diabetes and weight-loss drugs like Ozempic, Wegovy, Mounjaro, and Zepbound. The federal agency is examining reports of adverse side effects, such as hair loss, suicidal ideation, and aspiration, linked to these medications. Glucagon-like peptide-1 (GLP-1)

FDA Investigates Ozempic, Other Diabetes and Weight-Loss Drugs for Suicide, Hair Loss Side Effects Read More »

Scroll to Top